ALA 1.61% 15.3¢ arovella therapeutics limited

Ann: Board Changes, page-26

  1. 1,241 Posts.
    lightbulb Created with Sketch. 184
    Bollocks to the 'Sanofi thing'. They have made it abundantly clear that the oromist platform is a legacy business and wont spend another unneccessary dime on it. Good money after bad. I reckon theyd throw it at any half arsed buyer that came a-sniffing just to rid themselves of the management headache.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.